These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 28050310)

  • 1. Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments.
    Poirier AA; Aubé B; Côté M; Morin N; Di Paolo T; Soulet D
    Parkinsons Dis; 2016; 2016():6762528. PubMed ID: 28050310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premotor and nonmotor features of Parkinson's disease.
    Goldman JG; Postuma R
    Curr Opin Neurol; 2014 Aug; 27(4):434-41. PubMed ID: 24978368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring Braak's Hypothesis of Parkinson's Disease.
    Rietdijk CD; Perez-Pardo P; Garssen J; van Wezel RJ; Kraneveld AD
    Front Neurol; 2017; 8():37. PubMed ID: 28243222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease and alpha-synucleinopathies: from arising pathways to therapeutic challenge.
    Miraglia F; Betti L; Palego L; Giannaccini G
    Cent Nerv Syst Agents Med Chem; 2015; 15(2):109-16. PubMed ID: 25896035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the Evidence That Parkinson's Disease is a Prion Disorder, Which Originates in the Gut?
    Kujawska M; Jodynis-Liebert J
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30424585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ophthalmic disorders as a manifestation of Parkinson's disease].
    Chesnokova NB; Pavlenko TA; Ugrumov MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):124-131. PubMed ID: 29053133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-CNS pathogenic origin of Parkinson's disease.
    Choudhry H; Perlmuter LC
    J Neurol; 2017 Sep; 264(9):2027-2030. PubMed ID: 28808780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies.
    Perez-Pardo P; Kliest T; Dodiya HB; Broersen LM; Garssen J; Keshavarzian A; Kraneveld AD
    Eur J Pharmacol; 2017 Dec; 817():86-95. PubMed ID: 28549787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Parkinson's disease start in the gut?
    Lionnet A; Leclair-Visonneau L; Neunlist M; Murayama S; Takao M; Adler CH; Derkinderen P; Beach TG
    Acta Neuropathol; 2018 Jan; 135(1):1-12. PubMed ID: 29039141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body side and predominant motor features at the onset of Parkinson's disease are linked to motor and nonmotor progression.
    Baumann CR; Held U; Valko PO; Wienecke M; Waldvogel D
    Mov Disord; 2014 Feb; 29(2):207-13. PubMed ID: 24105646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct alterations in Parkinson's medication-state and disease-state connectivity.
    Ng B; Varoquaux G; Poline JB; Thirion B; Greicius MD; Poston KL
    Neuroimage Clin; 2017; 16():575-585. PubMed ID: 28971008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor and non-motor features of Parkinson's disease - a review of clinical and experimental studies.
    Lima MM; Martins EF; Delattre AM; Proenca MB; Mori MA; Carabelli B; Ferraz AC
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):439-49. PubMed ID: 22483309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of Parkinson's disease.
    Lew M
    Pharmacotherapy; 2007 Dec; 27(12 Pt 2):155S-160S. PubMed ID: 18041935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's Disease and Cognitive Impairment.
    Yang Y; Tang BS; Guo JF
    Parkinsons Dis; 2016; 2016():6734678. PubMed ID: 28058128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-motor extranigral signs and symptoms in Parkinson's disease.
    Wolters ECh
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S6-12. PubMed ID: 20083010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The second brain and Parkinson's disease.
    Lebouvier T; Chaumette T; Paillusson S; Duyckaerts C; Bruley des Varannes S; Neunlist M; Derkinderen P
    Eur J Neurosci; 2009 Sep; 30(5):735-41. PubMed ID: 19712093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A neuroscience perspective of the gut theory of Parkinson's disease.
    Smith LM; Parr-Brownlie LC
    Eur J Neurosci; 2019 Mar; 49(6):817-823. PubMed ID: 29446158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Threshold Theory for Parkinson's Disease.
    Engelender S; Isacson O
    Trends Neurosci; 2017 Jan; 40(1):4-14. PubMed ID: 27894611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal Dysfunction in Parkinson's Disease.
    Pfeiffer RF
    Curr Treat Options Neurol; 2018 Oct; 20(12):54. PubMed ID: 30361783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-gut-microbiota axis in Parkinson's disease.
    Mulak A; Bonaz B
    World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.